NASDAQ:ALQA - Alliqua Biomedical Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0.30 (1.20%)
Get New Alliqua Biomedical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALQA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALQA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
This price target is based on 0 analysts offering 12 month price targets for Alliqua Biomedical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
N/A
The current consensus among 0 investment analysts is to n/a stock in Alliqua Biomedical. This rating has held steady since December 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/16/2019HC WainwrightReiterated RatingNeutralLow
i
Rating by S. Ramakanth at HC Wainwright
1/8/2018HC WainwrightDowngradeBuy ➝ Neutral$4.50 ➝ $2.80High
i
Rating by Swayampakula Ramakanth at HC Wainwright
1/3/2018HC WainwrightSet Price TargetBuy$5.00High
i
Rating by Swayampakula Ramakanth at HC Wainwright
9/18/2017HC WainwrightReiterated RatingBuy$15.00Low
i
Rating by Swayampakula Ramakanth at HC Wainwright
8/11/2017HC WainwrightSet Price TargetBuy$20.00High
i
Rating by Swayampakula Ramakanth at HC Wainwright
7/4/2017HC WainwrightLower Price TargetBuy$25.00 ➝ $15.00Low
i
Rating by Swayampakula Ramakanth at HC Wainwright
5/11/2017HC WainwrightSet Price TargetBuy$20.00Low
i
Rating by Swayampakula Ramakanth at HC Wainwright
4/11/2017CowenReiterated RatingOutperform$15.00Low
i
4/7/2017HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $15.00Medium
i
Rating by Swayampakula Ramakanth at HC Wainwright
3/8/2017Chardan CapitalLower Price TargetBuy ➝ Buy$20.00 ➝ $12.50High
i
11/8/2016HC WainwrightReiterated RatingBuyN/A
i
Rating by Swayampakula Ramakanth at HC Wainwright
10/7/2016HC WainwrightReiterated RatingBuyN/A
i
Rating by Swayampakula Ramakanth at HC Wainwright
8/10/2016HC WainwrightLower Price TargetBuy$40.00 ➝ $25.00N/A
i
Rating by Swayampakula Ramakanth at HC Wainwright
7/10/2016Chardan CapitalReiterated RatingBuyN/A
i
Rating by Keay Nakae at Chardan Capital
5/11/2016HC WainwrightReiterated RatingBuyN/A
i
Rating by Swayampakula Ramakanth at HC Wainwright
(Data available from 4/22/2016 forward)
Alliqua Biomedical logo
Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $2.81
$2.20
$3.23

52 Week Range

Now: N/A

Volume

371,516 shs

Average Volume

114,400 shs

Market Capitalization

$13.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Alliqua Biomedical?

The following sell-side analysts have issued reports on Alliqua Biomedical in the last year:
View the latest analyst ratings for ALQA.

What is the current price target for Alliqua Biomedical?

0 Wall Street analysts have set twelve-month price targets for Alliqua Biomedical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Alliqua Biomedical in the next year.
View the latest price targets for ALQA.

What is the current consensus analyst rating for Alliqua Biomedical?

Alliqua Biomedical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ALQA.

What other companies compete with Alliqua Biomedical?

How do I contact Alliqua Biomedical's investor relations team?

Alliqua Biomedical's physical mailing address is 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047. The company's listed phone number is 215-702-8550 and its investor relations email address is [email protected] The official website for Alliqua Biomedical is www.alliqua.com.